Fleischner guidelines

Fleischner Society Guidelines for Incidentally Detected Pulmonary Nodules on CT

Current: Fleischner Society 2017 guideline — current as of mid-2026The Fleischner Society (independent thoracic-imaging society — NOT the ACR; not a 'RADS')
Lungs / thoraxCT

The Fleischner Society guidelines are consensus recommendations for how to follow up small pulmonary nodules discovered incidentally on a CT scan done for some other reason. Rather than assigning a category, they suggest a follow-up direction — for example, no routine imaging, an optional or definite repeat CT at a suggested interval, or further workup — based on the nodule's type and size, whether there are one or several, and the patient's cancer risk. They are deliberately not a screening tool and not a categorical lexicon; the aim is to avoid unnecessary repeat scans for trivial nodules while ensuring meaningful ones are tracked. They pair naturally with Lung-RADS as the 'incidental versus screening' counterpart.

Version history & what changed

  1. Fleischner 2017 (unified incidental-nodule guideline)2017Current

    Combined the previously separate solid-nodule and subsolid-nodule guidance into a single, simplified set of recommendations, raised the minimum nodule size that triggers routine follow-up, expressed follow-up timing as ranges rather than fixed dates, and added guidance for multiple nodules.

  2. 2013 subsolid-nodule recommendations2013

    Provided dedicated guidance for ground-glass and part-solid nodules, which the 2017 guideline later absorbed.

  3. 2005 solid-nodule statement2005

    The original Fleischner guidance, limited to small solid nodules; superseded by the unified 2017 document.

How the system is structured

Fleischner is a recommendation framework, not a category lexicon: it does not output a number or grade. Instead, the radiologist locates a nodule along several axes — its type (solid versus subsolid, with subsolid split into pure ground-glass and part-solid), its size, whether it is single or multiple, and the patient's risk level (low versus high) — and arrives at a suggested follow-up action. The precise size thresholds and recommended intervals should be read directly from the official 2017 Radiology paper.

  • No routine follow-upFor the smallest or clearly low-risk nodules, where the chance of cancer is negligible (also typical benign patterns such as perifissural nodules).
  • Optional / discretionary follow-up CTBorderline or indeterminate cases where a repeat scan may be considered but is not mandatory.
  • Definite surveillance CTA recommended repeat CT (sometimes a sequence over time) to confirm stability or detect growth.
  • Further workup / consider tissue samplingFor larger or more suspicious nodules, escalation toward PET-CT, biopsy, or specialist referral.

These are our plain-language summaries. For the exact criteria, thresholds, and management rules, see the official source.

Latest on Fleischner guidelines

How it compares

Fleischner and Lung-RADS are complementary, not competing: Fleischner handles nodules found by chance on a non-screening CT, while Lung-RADS handles nodules found during organized low-dose CT lung-cancer screening of high-risk people. Fleischner is consensus guidance expressed as follow-up directions, whereas Lung-RADS is a categorical reporting system tied to screening programs. They use different size thresholds and decision logic, so the same nodule can yield different recommendations under each — they should not be substituted for one another. Fleischner also differs from disease-specific or screening guidelines from other bodies (e.g. NCCN, ACCP, BTS).

Evidence & controversy

The 2017 guideline is the most widely cited reference for incidental pulmonary nodules and is broadly endorsed, with an educational companion clarifying its application. Real-world adherence, however, is imperfect: surveys show high awareness but inconsistent conformance when radiologists are tested on actual cases, and more recent data suggest radiologists self-report high adherence yet tend to overestimate how strong the underlying evidence base is. A 2026 comparison with Lung-RADS v2022 reinforced that, for identical solid nodules, the two systems diverge in follow-up timing and biopsy thresholds and are not interchangeable. The principal critiques are interobserver variability in nodule measurement/classification and the risk of both under- and over-follow-up when the guideline is applied loosely.

Frequently asked questions

Is Fleischner a 'RADS' like Lung-RADS or TI-RADS?
No. It is a set of consensus follow-up recommendations from the Fleischner Society, not a numbered category system and not an ACR product.
When do the Fleischner guidelines apply?
To pulmonary nodules found incidentally on a CT done for another reason, in adults from about age 35 up. They do not apply to lung-cancer screening exams.
Who is excluded?
They are not intended for lung-cancer screening, for people with a known or suspected cancer, or for immunocompromised patients — those situations need different pathways.
Does following the guideline mean a nodule is cancer?
No. Most incidental nodules are benign; the recommendation simply tells the care team whether and when to recheck.
Is the 2017 version still current?
Yes, as of 2026. A 2024 Fleischner publication updated thoracic-imaging terminology only and did not change the nodule follow-up recommendations.

Glossary

Fleischner Society
An independent international thoracic-imaging society that issues consensus statements, including the incidental pulmonary nodule guidelines.
Incidental pulmonary nodule
A lung nodule found unexpectedly on a CT performed for an unrelated reason (not on a screening exam).
Pulmonary nodule
A small, roughly rounded spot in the lung (generally up to about 3 cm; larger lesions are called masses).
Solid nodule
A nodule of uniform soft-tissue density that obscures the lung behind it.
Subsolid nodule
An umbrella term for any nodule containing a hazy ground-glass component (pure ground-glass and part-solid types).
Ground-glass nodule (GGN)
A hazy nodule through which normal lung vessels remain visible, with no solid component.
Part-solid nodule
A nodule with both ground-glass and solid components; it carries the highest cancer risk among nodule types, and the solid part guides management.

Resources & links

Written by RadPigeon Editorial Team, Radiology news editorial teamMedical review pending
Last reviewed: 29 Jun 2026Last changed: 29 Jun 2026

RadPigeon is an independent radiology news digest and is not affiliated with or endorsed by The Fleischner Society (independent thoracic-imaging society — NOT the ACR; not a 'RADS'). “Fleischner guidelines” is a trademark of its owner and is named here only to refer to the system. Always consult the official source for the exact, current criteria.